ADVANZ Pharma (formerly Concordia)

ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more than 90 countries globally and have a direct commercial presence in more than 20 countries, including key countries in Europe,...

Pharmaceuticals,endocrinology,,medicines,,ophthalmology,anti-infective,pain & inflammation,neurological disorders,levothyroxine,nitrofurantoin,fusidic acid,prednisolone,carbimazole,and urology

Advanz pharma (formerly concordia) operates in the Pharmaceutical manufacturing industry.

Advanz pharma (formerly concordia)'s revenue is 11m - 100m

Advanz pharma (formerly concordia) has 11 - 50 employees.